Call for abstracts for ICM2021 is now open!
We are re-opening the call for abstracts for the International Conference on Mindfulness 2021, taking place from July 5-8, 2021. The theme of ICM2021 is ‘Diversity and Equality – leaving no one behind’. There are four conference tracks. Please submit your abstract under the theme most relevant to your work. Please note that it is now possible to submit a symposium session. To do so, please select the below "Symposium" link.
A SPECIAL NOTE TO RESEARCHERS WHO ALREADY SUBMITTED AN ABSTRACT FOR ICM2020!
If you already submitted and had your abstract approved for ICM2020 (which has been postponed), we ask you to re-submit. We do so for research purposes, since things may have developed in the year, since you submitted the data.
If your abstract was approved, you can tick the box: “abstract approved for ICM2020” when submitting your abstract. Please read the updated guidelines for abstracts below BEFORE you resubmit!
Deadline for abstract submissions is April 1, 2021
- you will receive an answer from the committee by May 15, 2021.
Please note that you need to register for the conference in order to present your abstract. You need to register before May 30, 2021, or your abstract will be removed from the program.
Please read the UPDATED submission guidelines below carefully before submitting your abstract.
The four scientific tracks:
- Mechanisms of mindfulness and compassion
- Mindfulness and compassion in healthcare
- Mindfulness and compassion in education
- Mindfulness and compassion in business and politics.
The scientific committee evaluates abstracts based on the following criteria: Quality of study design and data sources, clarity of theoretical framework, originality, relevance of the study objective(s), coherence between results and conclusions, and quality of analysis.
Abstracts will be reviewed by at least three members of the international scientific committee for ICM2021. The following criteria apply:
- Does the research provide new insights to the field?
- Is the study design valid and appropriate?
- Has data been collected and processed?
- Have (preliminary) results been found?
- Have implications for the field been described?
Updated guidelines for abstract submission:
- Submit your abstract in English
- Only one author can be listed as the presenter. Please submit the authors full first and last name.
- Please note the scientific track both in the title of the file and on the actual document.
- Note whether your abstract is submitted for ORAL or POSTER presentation, or EITHER
- The abstract should be a max. of 300 words (references not included)
- Write a short title and avoid subtitles. Do not use all-capital letters, abbreviations or acronyms in the abstract title.
- Please provide a physical location and calendar time for where and when the study was carried out.
- Please provide the Authors email address.
- Please provide the Author affiliation.
- Please note if the abstract should be reviewed as part of a symposium session.
- Upon submission, the Author confirms that the information is correct, and agrees that the content cannot be modified or corrected after submission without contacting the conference organization.
- Accepted abstracts will be published exactly as received upon final submission.
- The submitting person warrants that the publication of the abstract does not infringe any third party rights including, but not limited to, intellectual property rights.
- please follow the below structure for abstract content:
State the objective and purpose of the study.
Describe the study design, the physical framework (such as a clinic or hospital), the study population, data collection, intervention techniques, and methods of analysis.
Present the primary quantitative or qualitative results followed by confidence intervals or level of significance in statistical data, if appropriate. This section should present data and not a statement saying: ”data to be discussed”. If relevant, state if results are preliminary.
Only include conclusions directly supported by your data. Discuss if any recommendations could be recommended as a result of the study, such as:
- New or improved prevention or treatment methods/offers.
- New procedures or health policy guidelines.